Published in Cancer Invest on June 01, 2010
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun (2012) 1.48
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis (2012) 1.14
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncol (2016) 1.13
Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci (2011) 1.10
Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) (2011) 0.88
Cognitive impact of cytotoxic agents in mice. Psychopharmacology (Berl) (2014) 0.83
The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat. PLoS One (2011) 0.80
MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. J Neurosci (2013) 0.79
Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An (18)F-FDG PET/CT study. Oncol Lett (2014) 0.79
Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models. J Cancer (2011) 0.78
Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Sci Rep (2016) 0.77
Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol (2016) 0.76
Protective effects of fractions from Artemisia biennis hydro-ethanolic extract against doxorubicin-induced oxidative stress and apoptosis in PC12 cells. Iran J Basic Med Sci (2016) 0.75
Higher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors. Front Hum Neurosci (2015) 0.75
A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age. Neurotoxicology (2016) 0.75
The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory. Neurobiol Learn Mem (2017) 0.75
The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc. Sci Rep (2017) 0.75
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 16.14
Small sample inference for fixed effects from restricted maximum likelihood. Biometrics (1997) 16.06
Mechanisms and functional implications of adult neurogenesis. Cell (2008) 14.50
Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec (1991) 11.44
Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci (2006) 5.89
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer (2004) 3.50
Stress and adult neurogenesis. Hippocampus (2006) 2.74
Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci (2000) 2.59
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer (2007) 2.43
Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol (2008) 2.38
P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev (1999) 2.34
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol (2006) 2.34
Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther (1990) 2.26
Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience (2001) 1.94
Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol (2007) 1.69
A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol (2005) 1.62
Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry (2003) 1.53
IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci (2003) 1.50
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res (2007) 1.48
Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proc Natl Acad Sci U S A (2006) 1.46
Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience (1998) 1.46
Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res (2002) 1.41
Health profiles in 5836 long-term cancer survivors. Int J Cancer (2003) 1.23
5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci (2008) 1.22
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97
Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03
Citation and readership metrics: how does Neurology measure up? Neurology (2008) 2.61
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet (2003) 2.58
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25
Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
SWAN MRI revealing multiple microhemorrhages secondary to septic emboli from mucormycosis. Neurology (2012) 1.97
Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke (2008) 1.87
Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol (2011) 1.79
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst (2009) 1.56
Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55
Honorary and ghost authorship. BMJ (2011) 1.55
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer (2001) 1.52
Cancer-related fatigue and sleep disorders. Oncologist (2007) 1.47
Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol (2013) 1.46
Ca2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity. J Physiol (2007) 1.45
Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI. J Magn Reson Imaging (2003) 1.45
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43
Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40
Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med (2002) 1.39
Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav (2008) 1.39
The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem Pharmacol (2008) 1.39
Fatigue associated with cancer and its treatment. Support Care Cancer (2001) 1.38
Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32
What's the problem with generic antiepileptic drugs?: a call to action. Neurology (2007) 1.30
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev (2012) 1.29
Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28
Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer (2004) 1.28
Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Management of cancer-related fatigue. Cancer Invest (2005) 1.26
Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat (2006) 1.24
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24
Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008. Am J Public Health (2012) 1.23
Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet (2006) 1.19
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19
Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc (2010) 1.19
Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol (2012) 1.15
Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med (2009) 1.15
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther (2004) 1.14
Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13
The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13
A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13
Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology (2005) 1.13
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer (2013) 1.12
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol (2009) 1.11
Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer (2011) 1.11
Caring for Somali women: implications for clinician-patient communication. Patient Educ Couns (2007) 1.10
Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09
Patient-reported outcome measures suitable to assessment of patient navigation. Cancer (2011) 1.09
Mouse brain kaleidoscope. Neurology (2013) 1.08
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07
Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity. Toxicol Sci (2004) 1.05
Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials (2012) 1.03
2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum. Toxicol Sci (2008) 1.02
Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res (2006) 1.01
The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00
Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98